Background
==========

Intervertebral disc degeneration (IDD) is an important cause of low back pain, which affects patient quality of life and causes heavy socioeconomic burdens \[[@b1-medscimonit-21-3449],[@b2-medscimonit-21-3449]\]. Currently, low back pain is mainly treated by medication combined with physiotherapy. Despite progress in surgical therapy, it is not curative and is related with several complications \[[@b3-medscimonit-21-3449]\]. Fortunately, gene therapy has attracted more attention in recent years \[[@b4-medscimonit-21-3449]\].

Several studies have unveiled a large number of genes or proteins that are implicated in IDD. For example, a former study has demonstrated that *axin2* and *Caveolin-1* are down-regulated in IDD \[[@b5-medscimonit-21-3449]\]. Another study also suggests that expression of IL-1β is significantly higher in IDD \[[@b6-medscimonit-21-3449]\], and IL-1β provokes the expression of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF), bringing about angiogenesis in human IDD \[[@b7-medscimonit-21-3449]\]. Moreover, growth factors including BMP2 as well as TGF-β1 have recently been suggested to enhance the generation of proteoglycans by nucleus pulposus (NP) cells \[[@b8-medscimonit-21-3449]\]. Degradation of metalloproteinases (MMPs) has been indicated to be connected with IDD \[[@b9-medscimonit-21-3449]\]. Using a combination of a variety of growth factors has also been proposed to be appropriate to treat IDD, and platelet-rich plasma (PRP) is the source of these growth factors and has inhibitory effects on IDD in a rabbit model \[[@b10-medscimonit-21-3449],[@b11-medscimonit-21-3449]\]. Targeting dysregulated genes has been suggested in animal IDD models, with inspiring results \[[@b12-medscimonit-21-3449]\]. Nevertheless, dysregulation of gene expression is very complicated. Therefore, it is of great importance to elucidate the mechanisms underlying IDD at molecular levels.

Recently, aberrant expression of long non-coding RNAs (lncRNAs) is shown to cause disordered gene expression. LncRNAs are mRNA-like transcripts ranging in length from 200 nt to 100 kb, and they lack significant open reading frames \[[@b13-medscimonit-21-3449],[@b14-medscimonit-21-3449]\]. In spite of this, accumulating studies have indicated that lncRNAs play crucial roles in many biological processes and human diseases \[[@b15-medscimonit-21-3449],[@b16-medscimonit-21-3449]\]. For example, Wan et al. \[[@b17-medscimonit-21-3449]\] demonstrated that over-expressed lncRNA RP11-296A18.3 induced the up-regulation of *FAF1*, which ultimately enhanced the abnormal apoptosis of disc cells. Wan et al. \[[@b17-medscimonit-21-3449]\] also suggested the crucial roles of differentially expressed lncRNA in the nucleus pulposus of IDD, in which lncRNA-mRNA microarray profile GSE56081 was used. However, there are few studies investigating the role of lncRNAs in IDD. As a result, identifying the aberrant lncRNAs in IDD is still quite a challenge.

In our study, we intended to use the same microarray profile to further identify the differentially expressed lncRNA and mRNAs. Moreover, gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, construction of lncRNA-mRNA weighted coexpression network, and protein-protein interaction (PPI) network were used to elucidate the molecular mechanism in the process of IDD. We believe that different results obtained from the microarray profile of Wan et al. might provide a profound understanding of IDD.

Material and Methods
====================

Tissue samples and data acquisition
-----------------------------------

The gene expression data of GSE56081 deposited by Wan et al. \[[@b17-medscimonit-21-3449]\] was downloaded from the National Center of Biotechnology Information (NCBI) Gene Expression Omnibus (*<http://www.ncbi.nlm.nih.gov/geo/>*) database, which was on the basis of GPL15314 platform of Arraystar Human LncRNA microarray V2.0 (Agilent_033010 Probe Name version). A total of 10 samples (5 human control nucleus pulposus tissues and 5 degenerative nucleus pulposus tissues) were included for the development of this microarray.

Data preprocessing
------------------

Expression data of probes were converted to corresponding genes symbols according to the annotation of GPL15314 platform. Aggregate() function of R was used to compute the average expression value, which was used for genes corresponding to multi-probes, and KNN method \[[@b18-medscimonit-21-3449]\] of Impute package of R \[[@b19-medscimonit-21-3449]\] was used to add the missing values of probes.

Then, quantile normalization was carried out using preprocessCore package of R \[[@b20-medscimonit-21-3449]\]. Subsequently, the expression matrix was obtained.

Identification of differentially expressed lncRNAs and mRNAs
------------------------------------------------------------

Limma (linear models for microarray data) package \[[@b21-medscimonit-21-3449]\] in R was used to identify differentially expressed lncRNAs and mRNAs between the 2 groups through use of the *t* test. Multiple testing correction was implement by calculating the Benjamini-Hochberg \[[@b22-medscimonit-21-3449]\] false discovery rate (FDR). \|log2 fold-change\| \>1 and an FDR \<0.05 were regarded as the criteria for differential expression.

Gene ontology (GO) and pathway enrichment analysis
--------------------------------------------------

GO analysis is frequently used in functional enrichment studies of large-scale genes \[[@b23-medscimonit-21-3449]\]. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was performed to analyze the biological pathways, involving the differentially expressed mRNAs. In the current study, TargetMine (*<http://targetmine.nibio.go.jp>*) \[[@b24-medscimonit-21-3449]\] was used to investigate the functional enrichment condition for the up- and down-regulated differentially expressed mRNAs. FDR less than 0.05 was selected as the threshold.

The construction of lncRNA-mRNA weighted coexpression network
-------------------------------------------------------------

WGCNA package \[[@b25-medscimonit-21-3449]\] in R was used to construct the lncRNA/mRNA coexpression network. The network construction steps included the following: (1) Network construction: the lncRNA-mRNA weighted coexpression network is fully specified by its adjacency matrix a~mn~, and a~mn~ encodes the network connection strength between nodes m and n. In order to calculate the adjacency matrix, the default approach defines the co-expression similarity S~mn~ as the absolute value of the correlation coefficient between nodes of m and n: S~mn~=\|cor(a~m~, a~n~)\|. The weighted adjacency a~mn~ between 2 genes is proportional to their similarity on a logarithmic scale with β ≥0.8, log(a~mn~)=β×log(S~mn~). Adjacency functions were obtained by approximate scale-free topology criterion. Then, the adjacency matrix was converted into topology matrix; (2) Module detection: we applied Dynamic Tree Cut method and Static Tree Cut method to detect modules with a minimum of 30 lncRNA/genes; and (3) Correlation analysis between disease information and gene module using the correlation coefficient method and gene significance (GS) value.

Then, we performed the GO and KEGG pathway enrichment analysis of genes in the module.

PPI network construction
------------------------

The interaction of the proteins were analyzed by means of the online STRING database (Search Tool for the Retrieval of Interacting Genes, *<http://string-db.org/>*) \[[@b26-medscimonit-21-3449]\] and the combined score \>0.9 was used as the cut-off criterion. Subsequently, Cytoscape (*<http://cytoscapeweb.cytoscape.org/>*) \[[@b27-medscimonit-21-3449]\] was used to display the PPI network.

Results
=======

Data preprocessing
------------------

On the basis of the annotation information of GPL56081, a total of 18 208 probes were identified, including 1970 lncRNAs and 16238 mRNAs. The data before and after normalization are shown in [Figure 1A and 1B](#f1-medscimonit-21-3449){ref-type="fig"}.

Identification of differentially expressed lncRNAs and mRNAs
------------------------------------------------------------

Based on the cut-off criteria, 135 significantly up- and 170 down-regulated lncRNAs were screened out. Moreover, 2133 significantly up- and 1098 down-regulated mRNAs were observed, as shown in [Figure 2](#f2-medscimonit-21-3449){ref-type="fig"}.

GO and pathway enrichment analysis
----------------------------------

TargetMine was used to identify GO enriched functions for significant differentially expressed mRNAs. Top 5 GO and KEGG terms are listed in [Table 1](#t1-medscimonit-21-3449){ref-type="table"}. Up-regulated genes were significantly enriched in macromolecule metabolic process (FDR=1.41E-03) and cellular macromolecule metabolic process (FDR=1.28E-03) of BP, membrane-bounded organelle (FDR=1.13E-08) and organelle (FDR=1.74E-07) of CC, RNA binding (FDR=1.31E-05), and nucleic acid binding (FDR=9.35E-04).

Significantly enriched KEGG pathways of up-regulated differentially expressed mRNAs were mainly on translation (FDR=2.24E-15) and cellular responses to stress (FDR=6.40E-10). However, the significant functions and pathways of down-regulated genes were not identified.

The construction of lncRNA-mRNA weighted coexpression network
-------------------------------------------------------------

In the current study, a total of 7 weighted coexpression sub-networks were identified. The results of correlation analysis demonstrated that in addition to the grey module, the other 6 modules were highly relevant in intervertebral disc degeneration, as shown in [Table 2](#t2-medscimonit-21-3449){ref-type="table"} and [Figure 3](#f3-medscimonit-21-3449){ref-type="fig"}. Then, lncRNA-mRNA weighted coexpression network was constructed on the basis of the genes with top 30 connectivity degrees in 6 modules and P value \<0.01. Among these, 8 lncRNAs were involved in the 4 modules (green module: CTC-523E23.5, RP4-639J15.1 and RP11-363G2.4; green-yellow module: CTD-2246P4.1 and LINC00917; magenta module: AC005082.12; purple module: MIR132 and RP11-38F22.1, [Table 3](#t3-medscimonit-21-3449){ref-type="table"}) and were up-regulated ([Figure 4A--4D](#f4-medscimonit-21-3449){ref-type="fig"}). Notably, in these modules, red diamond nodes represented up-regulated lncRNA, pink square nodes represented up-regulated genes, and pastel green square nodes represented down-regulated genes ([Figure 4](#f4-medscimonit-21-3449){ref-type="fig"}).

Then, we performed the GO and KEGG pathway enrichment analysis of genes in the module. As shown in [Table 4](#t4-medscimonit-21-3449){ref-type="table"}, the genes in the green module were significantly enriched in regulation of cell adhesion and response to axon injury. The genes in the green-yellow module were significantly enriched in positive regulation of cell migration and positive regulation of cell motion. The genes in the magenta module were significantly enriched in nucleotide catabolic process as well as nucleobase, nucleoside, nucleotide, and nucleic acid catabolic process. The genes in the purple module were significantly enriched in contractile fiber part and striated muscle thin filament.

PPI network
-----------

The PPI network of significantly up-regulated genes was constructed using the STRING database. As shown in [Figure 5](#f5-medscimonit-21-3449){ref-type="fig"}, several PPI nodes were high in connectivity degrees, as follows: *UBA52* (ubiquitin A-52 residue ribosomal protein fusion product 1, degree=51), RPS3 (ribosomal protein S3, degree=41), *RPL9* (ribosomal protein L9, degree=38), *RPL19* (ribosomal protein L19, degree=37), *RPL23* (ribosomal protein L23, degree=36), *RPL30* (ribosomal protein L30, degree=36), and *RPS14* (ribosomal protein S14, degree=36).

Discussion
==========

In this study, we identified 135 significantly up- and 170 down-regulated lncRNAs and 2133 significantly up- and 1098 down-regulated mRNAs. Additionally, up-regulated *UBA52* had the highest connectivity degree in PPI network and was remarkably enriched in the pathway of metabolism of proteins. lncRNA-mRNA weighted coexpression network analysis showed that a total of 8 key lncRNAs were identified and were remarkably higher in IDD samples relative to normal tissues, for example, lncRNA LINC00917 and CTD-2246P4.1 were identified in the green-yellow module. These lncRNAs and their interacting genes may be responsible for IDD development and merit further consideration.

Significantly, up-regulated *UBA52* had the highest connectivity degrees in PPI network and was remarkably enriched in the pathway of metabolism of proteins in our study. The intervertebral disc (IVD), a specialized fibrocartilaginous connective tissue, is mainly composed of the cell and extracellular matrix (ECM), and the molecular components of ECM are collagen, elastin, and proteoglycans \[[@b28-medscimonit-21-3449]\]. Generally, the destruction of ECM is believed to be an important cause of IDD because the degradation of ECM help endothelial cells to migrate to further induce the generation of neovascularization \[[@b29-medscimonit-21-3449],[@b30-medscimonit-21-3449]\]. MMPs are demonstrated to be the major proteolytic enzymes responsible for destruction of the ECM in the IVD \[[@b31-medscimonit-21-3449]\]. UBA52 is a fusion protein composed of ubiquitin and ribosomal protein. Moreover, ubiquitin proteins are encoded by some genes, including *UBA52* and *UBA80*, and are typically related with tagging proteins for proteosome degradation \[[@b32-medscimonit-21-3449],[@b33-medscimonit-21-3449]\]. A previous study has demonstrated that extracellular ubiquitin increases MMP-2 protein level and enhances the migration of endothelial cells \[[@b34-medscimonit-21-3449]\]. In light of these results, we infer that inhibiting the expression of *UBA52* may be a good strategy in the treatment of IDD by reducing the ubiquitin proteins levels to further suppress the destruction of ECM.

In the green-yellow module, lncRNA LINC00917 and CTD-2246P4.1 were remarkably higher in IDD samples relative to normal tissues. Moreover, their interacted genes, such as up-regulated *SPHK1* and down-regulated *EGFR,* were significantly enriched in positive regulation of cell migration. Several growth factors have been demonstrated to increase endothelial cell migration to further induce the generation of neovascularization \[[@b30-medscimonit-21-3449]\]. Significantly, the loss of ECM and infiltration of blood vessels are 2 characteristics of IDD \[[@b28-medscimonit-21-3449]\]. *SPHK1* is a members of the SPHKs family, which has been indicated to play a crucial role in cell migration \[[@b35-medscimonit-21-3449]\]. Moreover, growing evidence has demonstrated that *SPHK1* participates in the production of angiogenesis. *SPHK1* overexpression promoted endothelial cells survival in the absence of extracellular matrix and played a crucial role in vascular generation \[[@b36-medscimonit-21-3449]\]. In the current study, the level of *SPHK1* was up-regulated. Accordingly, *SPHK1* might be a potential biomarker in the process of IDD through increasing endothelial cell migration to further induce the generation of neovascularization. Several previous studies have indicated that the abnormal expression of lncRNAs may dysregulate the expression of their neighboring genes \[[@b37-medscimonit-21-3449]\]. Our findings suggest that the aberrant expression of *SPHK1* may be caused by the up-regulated LINC00917 or CTD-2246P4.1, to further influence the occurrence of IDD. Therefore, lncRNAs LINC00917 and CTD-2246P4.1 may play a key role in the development of IDD via interacting with *SPHK1*. However, this assumption needs to be further investigated.

Furthermore, our study also identified the other 6 differentially expressed lncRNAs as well as hundreds of differentially expressed genes in different modules. CTC-523E23.5, RP4-639J15.1, and RP11-363G2.4 were identified and could interact with Integrin, Alpha 11 (ITGA11) in the green module. ITGA11 is shown to be differentially expressed and is associated with cell proliferation in IVD \[[@b38-medscimonit-21-3449]\]. AC005082.12 was screened out and could interact with Ephrin-A3 (EFNA3) in the magenta module. MIR132 and RP11-38F22.1 could interact with Cathepsin L (CTSL) in the purple module. CTSL is demonstrated to degrade ECM and basement membrane components \[[@b39-medscimonit-21-3449]\]. The destruction of ECM has been regarded to be an important cause of IDD \[[@b29-medscimonit-21-3449],[@b30-medscimonit-21-3449]\]. Although the underlying mechanisms of these key lncRNAs in the development of IDD have not been fully discussed in our study, our results indicate that they may contribute to IDD development to some extent.

However, there were still some limitations in the current study. First, sample size was small which might limit the validity of the results. Second, no animal experiments were performed in our study to further validate these results. Thus, large sample sizes and more experiments, such as RNA interference and fluorescence *in situ* hybridization, are required in future work to more comprehensively elucidate the mechanisms of lncRNAs in the development of IDD.

Conclusions
===========

lncRNAs LINC00917, CTD-2246P4.1, CTC-523E23.5, RP4-639J15.1, RP11-363G2.4, AC005082.12, MIR132, and RP11-38F22.1 were differentially expressed and might play important roles in the development of IDD. Key genes, such as *UBA52* and *SPHK1*, may be pivotal biomarkers for IDD. Nevertheless, further experiments are required to validate their effects and mechanisms in IDD.
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![(**A**) Box plot of gene expressions in human control nucleus pulposus tissue and degenerative nucleus pulposus tissue before normalization. (**B**) Box plot of gene expressions in human control nucleus pulposus tissue and degenerative nucleus pulposus tissue after normalization. The X axis represents samples and the Y axis represents expression level of genes after log2-transformation. The black line in the center is the median of expression value, and consistent distribution implies a good normalization.](medscimonit-21-3449-g001){#f1-medscimonit-21-3449}

![Volcano plots of fold change values of Probesets *vs.* transformed (log10) and FDR of case group relative to control group. Green points stand for differentially expressed lncRNAs and mRNAs. Red points represent lncRNAs and mRNAs, which are not differentially expressed.](medscimonit-21-3449-g002){#f2-medscimonit-21-3449}

![Significant modules in the lncRNA-mRNA weighted coexpression network based on the gene significance (GS) value.](medscimonit-21-3449-g003){#f3-medscimonit-21-3449}

![The sub-network of genes with top 30 connectivity degrees in green module (**A**), green-yellow module (**B**), magenta module (**C**), and purple module (**D**). Red diamond nodes stand for up-regulated lncRNA; pink nodes stand for up-regulated genes; pastel green nodes stand for down-regulated genes.](medscimonit-21-3449-g004){#f4-medscimonit-21-3449}

![The protein-protein interaction network of significantly up-regulated genes.](medscimonit-21-3449-g005){#f5-medscimonit-21-3449}

###### 

The top 5 Gene Ontology (GO) functions and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment analysis of up-regulated differentially expressed genes.

  Ontology                       Term                                            FDR           Count
  ------------------------------ ----------------------------------------------- ------------- -------
  GO terms                                                                                     
  GO-BP                          Metabolic process                               2.55×10^−2^   827
  GO-BP                          Macromolecule metabolic process                 1.41×10^−3^   650
  GO-BP                          Cellular macromolecule metabolic process        1.28×10^−3^   610
  GO-BP                          Cellular component organization or biogenesis   5.10×10^−3^   471
  GO-BP                          Cellular component organization                 1.33×10^−3^   468
  GO-CC                          Intracellular                                   2.64×10^−7^   972
  GO-CC                          Intracellular part                              9.77×10^−7^   963
  GO-CC                          Organelle                                       1.74×10^−7^   946
  GO-CC                          Membrane-bounded organelle                      1.13×10^−8^   903
  GO-CC                          Intracellular organelle                         2.34×10^−7^   837
  GO-MF                          Binding                                         1.03×10^−2^   904
  GO-MF                          Organic cyclic compound binding                 3.76×10^−2^   309
  GO-MF                          Heterocyclic compound binding                   2.22×10^−2^   305
  GO-MF                          Nucleic acid binding                            9.35×10^−4^   262
  GO-MF                          RNA binding                                     1.31×10^−5^   185
  KEGG pathways                                                                                
  KEGG                           Gene expression                                 2.44×10^−6^   168
  Metabolism of proteins         9.99×10^−8^                                     116           
  Cellular responses to stress   6.40×10^−10^                                    64            
  Translation                    2.24×10^−15^                                    52            
  Alcoholism                     8.50×10^−10^                                    50            

BP -- biological process; CC -- cellular components; MF -- molecular function.

###### 

The results of correlation analysis based on correlation coefficient method.

  Module        ME purple     ME greenyellow   ME magenta    ME yellow     ME green      ME grey60     ME grey
  ------------- ------------- ---------------- ------------- ------------- ------------- ------------- -------------
  Significant   −0.81         −0.85            −0.85         −0.86         −0.9          −0.97         −0.034
  P value       4.93×10^−3^   1.80×10^−3^      1.67×10^−3^   1.29×10^−3^   4.65×10^−4^   4.19×10^−6^   9.27×10^−1^

###### 

The information of key lncRNAs in different modules.

  Module         Gene id             Gene name      Chromesome   log2FC
  -------------- ------------------- -------------- ------------ --------
  Purple         ENSG00000267200.1   MIR132         chr17        1.47
  Green          ENSG00000269086.2   CTC-523E23.5   chr19        1.81
  Green          ENSG00000236102.2   RP4-639J15.1   chr7         1.96
  Green yellow   ENSG00000267065.1   CTD-2246P4.1   chr17        1.53
  Green          ENSG00000229556.2   RP11-363G2.4   chr13        1.90
  Magenta        ENSG00000226816.2   AC005082.12    chr7         2.13
  Green yellow   ENSG00000168367.5   LINC00917      chr16        1.41
  Purple         ENSG00000258220.1   RP11-38F22.1   chr12        1.90

FC -- fold change.

###### 

The GO and KEGG pathways enrichment analysis of differentially expressed genes.

  Category             Term                                                                    Count   P value       Genes
  -------------------- ----------------------------------------------------------------------- ------- ------------- ---------------------------------------------------------------------------------------------------------------
  Green module                                                                                                       
  GO_BP                Regulation of cell adhesion                                             3       3.03×10^−2^   LAMA2, S1PR1, JAK2
  GO_BP                Response to axon injury                                                 2       3.92×10^−2^   TXN2, JAK2
  GO_BP                Regulation of cell migration                                            3       4.44×10^−2^   LAMA2, S1PR1, JAK2
  GO_BP                Activation of MAPKK activity                                            2       4.88×10^−2^   ZAK, JAK2
  GO_CC                Integral to plasma membrane                                             6       4.76×10^−2^   STX8, TSPAN31, ICAM3, ITGA11, HLA-DPA1, KCNJ2
  REACTOME_PATHWAY     Integrin cell surface interactions                                      3       1.43×10^−2^   LAMA2, ICAM3, ITGA11
  Greenyellow module                                                                                                 
  GO_BP                Positive regulation of cell migration                                   3       8.29×10^−3^   EGFR, SPHK1, F7
  GO_BP                Positive regulation of cell motion                                      3       9.97×10^−3^   EGFR, SPHK1, F7
  GO_BP                Positive regulation of locomotion                                       3       9.97×10^−3^   EGFR, SPHK1, F7
  GO_BP                Regulation of ATPase activity                                           2       2.46×10^−2^   TPM2, TNNI3
  GO_BP                Positive regulation of cell proliferation                               4       2.51×10^−2^   EGFR, FGF7, SPHK1, SHC1
  GO_MF                Cytoskeletal protein binding                                            5       7.94×10^−3^   EGFR, SUN2, FXYD5, TPM2, TNNI3
  GO_MF                Actin binding                                                           4       1.49×10^−2^   EGFR, FXYD5, TPM2, TNNI3
  GO_CC                Shc-EGFR complex                                                        2       2.97×10^−3^   EGFR, SHC1
  GO_CC                Striated muscle thin filament                                           2       2.21×10^−2^   TPM2, TNNI3
  Magenta module                                                                                                     
  GO_BP                Nucleotide catabolic process                                            3       3.95×10^−3^   SMUG1, NTHL1, AMPD3
  GO_BP                Nucleobase, nucleoside, nucleotide and nucleic acid catabolic process   3       5.09×10^−3^   SMUG1, NTHL1, AMPD3
  GO_BP                Nucleobase, nucleoside and nucleotide catabolic process                 3       5.09×10^−3^   SMUG1, NTHL1, AMPD3
  GO_BP                Nitrogen compound catabolic process                                     3       6.74×10^−3^   SMUG1, NTHL1, AMPD3
  GO_BP                Heterocycle catabolic process                                           3       8.81×10^−3^   SMUG1, NTHL1, AMPD3
  GO_MF                Oxidized base lesion DNA N-glycosylase activity                         2       5.77×10^−3^   SMUG1, NTHL1
  GO_MF                DNA N-glycosylase activity                                              2       2.10×10^−2^   SMUG1, NTHL1
  GO_MF                Hydrolase activity, hydrolyzing N-glycosyl compounds                    2       3.78×10^−2^   SMUG1, NTHL1
  Purple module                                                                                                      
  GO_CC                Contractile fiber part                                                  9       4.26×10^−3^   ACTG2, TNNT3, ACTA1, MYL2, TNNC2, MYL3, TNNC1, ANKRD1, LMAN1
  GO_CC                Striated muscle thin filament                                           4       4.34×10^−3^   TNNT3, ACTA1, TNNC2, TNNC1
  GO_CC                Contractile fiber                                                       9       6.42×10^−3^   ACTG2, TNNT3, ACTA1, MYL2, TNNC2, MYL3, TNNC1, ANKRD1, LMAN1
  GO_CC                Sarcomere                                                               8       7.00×10^−3^   TNNT3, ACTA1, MYL2, TNNC2, MYL3, TNNC1, ANKRD1, LMAN1
  GO_CC                Actin cytoskeleton                                                      14      8.75×10^−3^   PRKCZ, MYL2, HAX1, ACTA1, TNNC2, MYO1B, TNNC1, MYL3, SNCA, VILL, AMPH, LSP1, ACTG2, TNNT3
  GO_BP                Regulation of megakaryocyte differentiation                             3       5.55×10^−3^   TESC, HIST1H4L, PF4, HIST1H4D
  GO_BP                Negative regulation of protein metabolic process                        12      5.81×10^−3^   BAK1, PRKCZ, SET, EIF4EBP2, ANAPC5, SERPINA5, SNCA, CDC23, ANKHD1, MDM4, EIF2B3, PSMB9
  GO_BP                Negative regulation of cellular protein metabolic process               11      1.22×10^−2^   BAK1, PRKCZ, SET, EIF4EBP2, ANAPC5, SERPINA5, SNCA, CDC23, ANKHD1, EIF2B3, PSMB9
  GO_BP                Ventricular cardiac muscle morphogenesis                                4       1.53×10^−2^   MYL2, MYL3, TNNC1, COL11A1
  GO_BP                Nucleosome assembly                                                     7       1.60×10^−2^   HIST1H2AB, HIST1H2BB, HIST1H4L, TSPYL2, SET, HIST1H1A, HIST1H3E, HIST1H4D, HIST1H3G
  GO_MF                Carbohydrate binding                                                    16      2.02×10^−2^   EPM2A, HEXB, HK2, CHI3L1, POSTN, PF4, LMAN2, GYG1, LMAN1, ITGAM, TNFAIP6, SERPINA5, VEGFA, PKD1, FGF1, SELPLG
  KEGG_PATHWAY         Cardiac muscle contraction                                              8       3.55×10^−3^   UQCRC1, SLC9A6, ATP2A2, MYL2, MYL3, TNNC1, CACNG6, COX6C
  KEGG_PATHWAY         Systemic lupus erythematosus                                            7       4.03×10^−2^   HIST1H2AB, HIST1H2BB, TROVE2, HIST1H4L, HLA-DRB4, HIST1H3E, HIST1H4D, HIST1H3G, CTSG
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